Alginate from a heavily mucoid Pseudomonas aeruginosa strain and slime glycolipoprotein obtained from the revertant nonmucoid variant of the mucoid strain were tested for mitogenic activity on human peripheral lymphocytes and for degradation of 3H-labeled (3, 5, 15) .
alginate was not mitogenic as shown by [3H]thymidine uptake. Alginate did not show any basement membrane degradation, whereas slime glycolipoprotein exhibited basement-membrane-degrading activity from 35 to 450 ,ug/ml in a dose-related manner. This activity was inhibited by metal chelators but not thiol protease inhibitors.
The results suggest that alginate lacks the mitogenic and biodegrading activities of slime glycolipoprotein; these activities nevertheless need further investigation.
Mucoid strains of Pseudomonas aeruginosa are mainly isolated from sputum cultures of patients with cystic fibrosis, whereas infections by nonmucoid strains are characterized by tissue invasion associated with extensive necrosis and destructive vascular lesions with hemorrhage. Most of the mucoid strains produce only a rough type of lipopolysaccharide (6) . A heavily mucoid strain of P. aeruginosa was recently isolated in our clinical laboratory from blood cultures of a patient with drug-induced hepatitis attributed to antituberculous therapy. The extracellular material (slime) of the mucoid strain was characterized as alginate of high molecular weight (1), whereas the extracellular material of its revertant nonmucoid variant, obtained by serial passage on Trypticase soy agar, was characterized as similar to the glycolipoprotein (GLP) that is extracted from the slime layer of all seven Fisher immunotypes (2). Alginates are nontoxic and have been approved by the Food and Agriculture Organization-World Health Organization Expert Joint Committee for human consumption or therapeutic purposes (12) . In contrast, GLP has been shown to possess many biological properties comparable to those of the viable cells, whereas active immunization with GLP or passive immunization with rabbit anti-GLP protects mice against a lethal challenge with viable cells (3, 5, 15) .
The experiments reported in this paper were designed to examine whether the slime GLP of nonmucoid variants, derived from a mucoid P. aeruginosa strain, is mitogenic for human peripheral lymphocytes, a property of the slime GLP of the clinical nonmucoid P. aeruginosa isolates (13) . For comparison we used alginate from the parent mucoid strain and slime GLP from the smooth nonmucoid strain P. aeruginosa PAC IR. In addition, we explored the ability of these three extracellular materials to degrade basement membranes (BM), which contribute to the pathology of P. aeruginosa infection. We show that slime GLP, either from clinical nonmucoid P. aeruginosa isolates or from revertant nonmucoid variants, is mitogenic for human peripheral lym- To determine the labeling index, 100-pl samples of the stock solution of 3H-acetylated BM were hydrolyzed in 6 N HCI for 24 h at 100°C, and the amount of radioactivity solubilized was taken to reflect the total 3H present in a sample. Protein concentration was determined in a sample of the stock solution.
Assay for BM-degrading activity. The method for measuring BM-degrading activity was that of Salo et al. (14) . Assays were performed in sterilized and siliconized glass vials containing 100 pul of 3H-acetylated BM and made up to 2.5 ml with 50 mM Tris hydrochloride (pH 7.4)-200 mM NaCl-0.01% NaN3. Where indicated, 2 mM 1,10-phenanthroline monohydrate (Sigma Chemical Co., London), 10 mM disodium EDTA, or 5 mM phenylmethylsulfonyl fluoride (Sigma) was included. The assay was started by the addition of 100 ,ul of tested materials, and incubations were carried out at 35°C in a water bath shaker. At 0, 1, 6, and 24 h of incubation,
200-pul samples of the mixture were transferred to microcentrifuge tubes containing 100 pul of dioxane and vortexed to stop enzymatic activity. Undigested substrate was centrifuged out at 6,000 x g for 10 min, and 200-pul samples of the supernatants were transferred to vials containing 3.5 ml of Lumagel scintillation cocktail. Radioactivity was measured in a Beckman LS 1801 liquid scintillation spectrometer (counting efficiency, 31 to 33%). All determinations were carried out in triplicate.
To measure the starting amount of 3H-acetylated BM present in each assay vial, 50 IU of Clostridium collagenase (clostridiopeptidase A, EC 3.4.24.3, type VII; Sigma) was added to each vial at the end of the incubation period. The amount of radioactivity released after further 24 h of incubation was a measure of the total collagenous material available for degradation. Radioactivity Gel chromatography. Gel chromatography on a Sepharose CL-4B column (1.8 by 86 cm) was performed at room temperature with 0.1 M sodium phosphate-buffered saline (pH 7.4) containing 0.1% sodium dodecyl sulfate and 0.01% NaN3 (11) . Fractions of 2.8 ml were collected with a flow rate 0.25 ml/min and assayed for radioactivity or protein content. The void volume (V0) and total volume (Vt) were determined by using blue dextran and [14C]proline, respectively. In the experiments designed to study the molecular size of BM components, samples of 3H-acetylated BM were reduced and denatured by suspending them in 4 ml of 0.1 M phosphate-buffered saline (pH 7.4) containing 5 mM phenylmethylsulfonyl fluoride, 1% (wt/vol) sodium dodecyl sulfate, and 5% (vol/vol) 2-mercaptoethanol and heating then in a sealed tube at 100°C for 2 min. The mixture was incubated further at 37°C for 2 h and centrifuged at 6,000 x g for 10 min before chromatography. Native type IV collagen (1 mg/ml) from human placenta was used as a standard. dioxane (Table 1 ). In the absence of denaturants there was less than 1% release of 3H over a 6-h incubation period and less than 3% release of 3H over 24 h of incubation. The addition of dioxan (50%, vol/vol) to BM for short periods of time did not release any appreciable amount of radiolabel. Thus, dioxane was routinely used to quench the reaction in the samples that were removed from the incubation mixture. Treatment with 6 N HCl at 100°C for 24 h completely solubilized the radiolabeled BM. Clostridium collagenase could only release about 80% of the total radiolabel present in a sample, irrespective of the amount and the duration of treatment (Table 1) . This is in agreement with previous reports (16) , and it is attributed to the fact that noncollagenous moieties of BM are not solubilized by Clostridium collagenase. Thus, a distinction should be made between the total radiolabel present in a sample of BM and the maximal amount of substrate that is susceptible to collagenase-type enzymatic degradation. The enzyme activity in the present study is expressed as a percentage of the total collagenase-susceptible enzymatic degradation.
When the slime GLP was incubated with 3H-labeled BM, release of 3H was observed. The release of radioactivity was linear with time and reached a maximum after 6 h of incubation (Fig. 2) . This activity was also linear with protein content, at least within the range of 35 to 450 ,ug (dry weight) of slime GLP per ml of incubation buffer. In contrast to the above, the alginate did not produce any appreciable degradation of BM even at 2 mg (dry weight) per ml of incubation buffer. The BM degradation activity present in the slime GLP was completely inhibited by 2 mM 1,10-phenanthroline or 10 mM EDTA but was not affected by 5 mM phenylmethylsulfonyl fluoride.
The BM-degrading activity of the slime GLP preparation was studied with respect to the products formed by Sepharose 4B chromatography. The components of 3H-labeled BM from bovine lens were examined before and after the addition of the extracellular material. 3H-labeled BM were also examined after digestion by Clostridium collagenase. Chromatography of the acetylated BM on Sepharose 4B, after reduction and denaturation, showed four major peaks (Fig. 3a) . Peak A was eluted with VO, indicating a component of high molecular weight. Peaks B, C, and D were eluted with distribution coefficients (Kds) of 0.21, 0.42 and 0.79, respectively, indicating components of smaller molecular weight. Chromatography of type IV collagen on Sepharose 4B, after reduction and denaturation, produced three main peaks (Fig. 3a) , which were eluted with VO, with Kds of 0.42 and 0.79, coinciding with peaks A, C, and D of 3H-labeled BM, respectively.
Treatment of 3H-labeled BM with Clostridium collagenase eliminated completely peaks A and C but not peak B (Fig.   3b) . The above results indicate that components of BM similar in size to those of type IV collagen were degraded after incubation with Clostridium collagenase. The same components were degraded by the slime GLP preparation. The latter also degraded components of BM that were unaffected by Clostridium collagenase (peak B, Fig. 3b) . The above results also indicate the collagenous nature of the components of peaks A and C. In contrast, the components of peak B appear to be of a noncollagenous nature; these may be heparan sulfate proteoglycans or laminin of BM. With Clostridium collagenase the major product was eluted in a peak with Vt, indicating digestion products of low molecular weight, probably oligopeptides and tripeptides. Digestion products of similar size were obtained with the slime GLP in the presence or absence of 5 mM phenylmethylsulfonyl fluoride.
Slime GLP from the smooth nonmucoid strain P. aeruginosa PAC IR, used as control, exhibited the same activities as the slime GLP from the revertant nonmucoid variant. reported (4). This property has been implicated for possible in vivo consequences resulting in aberrant immunoregulation and inhibition of effective immune elimination of P. aeruginosa from the lungs of cystic fibrosis patients (4). However, it should be noted that the alginate moiety has no toxic properties and that, when combined with suitable bases, the alginates are edible. Furthermore, alginates in the form of fibers or powder have a marked hemostatic action, since they can be gradually absorbed by vascular tissues without ill effect and are therefore used as surgical dressings that can be left in the body (12) .
DISCUSSION
Using intact BM in their organized, physiological state, we have demonstrated that the slime GLP, but not the alginate, is capable of degrading BM. It appears that the slime GLP contains enzymes that are able to degrade BM in their intact form in a dose-related manner between 35 and 450 ,ug (dry weight) per ml of incubation buffer. These enzymes are apparently metaloproteases, since they can be inhibited by metal chelators such as 1,10-phenanthroline or EDTA. The thiol protease inhibitor phenylmethylsulfonyl fluoride did not interfere with activity. Sepharose 4B chromatography indicated that the digestion products of intact BM after incubation with slime GLP were of low molecular weight, probably oligopeptides and tripeptides, similar to those produced by Clostridium collagenase. The slime GLP fraction also degraded noncollagenous components of BM that were unaffected by Clostridium collagenase. These components may be either heparan sulfate proteoglycans or laminin, a matrix glycoprotein which is the major noncollagenous component of all BM. The nature of the origin and the mode of association of BM-degrading activity with slime GLP is under investigation.
Other investigators have reported that purified P. aeruginosa elastase produces rapid and extensive degradation of both laminin A and B chains, whereas P. aeruginosa alkaline protease degrades the A chain rapidly and the B chain slowly (7, 8) . We have shown that slime GLP has a protective effect in passive and active immunization (15) . It has been also reported that toxoids of elastase and alkaline phosphatase combined with a common protective antigen enhance immunogenicity of the antigen (9) . In view of that, it is possible that the presence of BM-degrading activity in the slime GLP preparations may be a contributory factor to the reported protective immunogenicity and as such strengthens our contention that slime GLP may be used for the preparation of polyvalent vaccines against P. aeruginosa infection.
